Biodegradable auricular prosthetic device

• US 7,163,557 B2
• Filed: 01/16/2002
• Issued: 01/16/2007
• Est. Priority Date: 01/16/2002
• Status: Expired due to Fees

• Current Assignee: Riccardo D'Eredita
• Original Assignee: Riccardo D'Eredita
• Inventors: D'Eredita, Riccardo
• Primary Examiner(s): Isabella; David J.
• Application Number:
  US10/501,641
• Publication Number:
  US 20050075733A1
• Time in Patent Office: 1,826 Days
• Field of Search: 623/1.38, 623/10, 623/11.11, 623/16.11, 623/23.64, 623/23.75, 606/151
• US Class Current: 623/10
• CPC Class Codes: A61F 11/202 Surgical middle-ear ventilation or drainage, e.g. permanent; Implants therefor
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61L 2430/14 for ear reconstruction or ear implants, e.g. implantable hearing aids
• CPC Class Codes: A61L 27/18 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: A61L 27/58 Materials at least partially resorbable by the body
• CPC Class Codes: C08L 85/02 containing phosphorus

Abstract

A biodegradable auricular prosthetic device is described, particularly but not exclusively devised for the treatment of otitis media, comprising a tubular body having axially opposed ends and flanged at least at one of the opposed ends and at least a portion of which is produced from a material subject to biological degradation in the presence of organic liquids, wherein at least the portion made of material subject to biological degradation is produced from a polymeric material selected from the group of polyphosphazenes.

Claims

1. A biodegradable auricular prosthetic device, particularly but not exclusively devised for the treatment of otitis media, comprising a tubular body having axially opposed ends and flanged at least at one of said opposed ends and at least a portion of which is produced from a material subject to biological degradation in the presence of organic liquids, characterized in that at least said portion made of material subject to biological degradation is produced from a polymeric material selected from the group of polyphosphazenes;

wherein said tubular body has a duct defined therethrough;

wherein at least said portion made of material subject to biological degradation has variable biodegradability characteristics along the axial extension of said tubular body; and

wherein said tubular body, in an intermediate portion thereof comprised between said ends, has a greater biodegradability with respect to the biodegradability of said flange.

2. The prosthetic device according to claim 1, wherein said body is flanged at both said opposed ends in a bobbin shape.

3. The prosthetic device according to claim 2, wherein there are incorporated into said polymeric material substances selected from the group consisting of drugs, growth factors, bacteriostatic substances, and bactericides.

4. The prosthetic device according to claim 3, wherein one of said flanges is made of a biodegradable polymeric material selected from the group of polyphosphazene, said biodegradable flange is located at said end of said tubular body having the greatest rate of biodegradability.

5. The prosthetic device according to claim 4, wherein the speed of degradation of said tubular body material is greater than the speed of degradation of said flange.

6. The prosthetic device according to claim 5, wherein said biodegradable flange further comprising a pointed appendage extending out therefrom, said appendage being adapted to perforate the tympanic membrane when inserted into an ear.

7. The prosthetic device according to claim 1, wherein said flange is oblique with respect to the axis of said tubular body, and said flange is located at said end of said tubular body having the lowest rate of biodegradability.

8. A biodegradable auricular prosthetic device for ventilating the middle ear of a patient, said prosthetic device comprising:

a tubular body having axially opposed ends and a duct defined therethrough, said tubular body being made of material subject to biological degradation selected from the group of polyphosphazenes, wherein said tubular body has variable biodegradability characteristics along the axial extension of said tubular body;

an inner flange attached to said end of said tubular body having the greatest rate of biodegradability, said inner flange being made of material subject to biological degradation selected from the group of polyphosphazenes; and

an outer flange attached to said end opposite said inner flange;

wherein there are incorporated into said polymeric material substances selected from the group consisting of drugs, growth factors, bacteriostatic substances, and bactericides;

wherein the speed of degradation of said tubular body material is greater than the speed of degradation of said inner flange.

9. The prosthetic device according to claim 8, wherein said inner flange further comprising a pointed appendage extending out therefrom, said appendage being adapted to perforate the tympanic membrane when inserted into the ear.

10. The prosthetic device according to claim 9, wherein said outer flange being made of material subject to biological degradation selected from the group consisting of polyphosphazenes.

11. The prosthetic device according to claim 10, wherein the speed of degradation of said tubular body material is greater than the speed of degradation of said outer flange.

12. A biodegradable auricular prosthetic device comprising:

a tubular body having axially opposed ends and a duct defined therethrough, said tubular body being made of material subject to biological degradation selected from the group of polyphosphazenes, wherein said tubular body has variable biodegradability characteristics along the axial extension of said tubular body;

an inner flange attached to said end of said tubular body having the greatest rate of biodegradability, said inner flange being made of material subject to biological degradation selected from the group of polyphosphazenes;

a pointed appendage extending out from said inner flange away from said tubular body, said appendage being made of material subject to biological degradation selected from the group of polyphosphazenes; and

an outer flange attached to said end opposite said inner flange, said outer flange being made of material subject to biological degradation selected from the group of polyphosphazenes;

wherein there are incorporated into said polymeric material substances selected from the group consisting of drugs, growth factors, bacteriostatic substances, and bactericides;

wherein the speed of degradation of said tubular body material is greater than the speed of degradation of said inner and outer flanges.